Free Trial

NovaBay Pharmaceuticals (NBY) SEC Filings & 10K Form

NovaBay Pharmaceuticals logo
$0.69 0.00 (-0.29%)
Closing price 07/14/2025 04:10 PM Eastern
Extended Trading
$0.72 +0.03 (+4.20%)
As of 09:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent NovaBay Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/04/2025
11:46 AM
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D
04/15/2025
11:40 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:46 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:50 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:11 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:18 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:22 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:30 AM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:30 PM
FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:33 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEF 14A
03/11/2025
3:35 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:07 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:08 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
02/06/2025
5:30 PM
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
3:58 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:58 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
01/23/2025
7:12 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
01/23/2025
7:13 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
3:27 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
5:06 PM
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G
01/10/2025
6:03 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
6:00 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:12 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
12/09/2024
6:05 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/26/2024
3:08 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/22/2024
3:27 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
7:10 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/13/2024
4:15 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/12/2024
3:52 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/08/2024
4:31 PM
Hudson Bay Capital Management LP (Filed by)
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
Form SC 13G/A
11/06/2024
3:46 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:15 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:19 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
10/16/2024
3:27 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:19 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFM14A
09/25/2024
4:17 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form PREM14A
09/20/2024
7:08 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
7:08 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
07/29/2024
3:25 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
6:18 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 424B4
07/26/2024
4:19 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form POS EX
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
07/25/2024
11:15 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
07/24/2024
7:49 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSEAMERICAN:NBY) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners